PH26103A - Solvates of B-lactam antibiotic - Google Patents

Solvates of B-lactam antibiotic Download PDF

Info

Publication number
PH26103A
PH26103A PH39508A PH39508A PH26103A PH 26103 A PH26103 A PH 26103A PH 39508 A PH39508 A PH 39508A PH 39508 A PH39508 A PH 39508A PH 26103 A PH26103 A PH 26103A
Authority
PH
Philippines
Prior art keywords
dmf
solution
mono
mixture
solvate
Prior art date
Application number
PH39508A
Other languages
English (en)
Inventor
Thomas Michael Echrich
Richard Charles Hoying
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PH26103A publication Critical patent/PH26103A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
PH39508A 1988-11-14 1989-11-10 Solvates of B-lactam antibiotic PH26103A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27154588A 1988-11-14 1988-11-14

Publications (1)

Publication Number Publication Date
PH26103A true PH26103A (en) 1992-02-06

Family

ID=23036044

Family Applications (1)

Application Number Title Priority Date Filing Date
PH39508A PH26103A (en) 1988-11-14 1989-11-10 Solvates of B-lactam antibiotic

Country Status (20)

Country Link
EP (1) EP0369687B1 (pt)
JP (1) JP2842640B2 (pt)
KR (1) KR0145556B1 (pt)
CN (1) CN1025333C (pt)
AT (1) ATE136306T1 (pt)
AU (1) AU614440B2 (pt)
CA (1) CA2002597C (pt)
DE (1) DE68926148T2 (pt)
DK (1) DK170701B1 (pt)
ES (1) ES2085281T3 (pt)
GR (1) GR3019677T3 (pt)
HU (1) HU203756B (pt)
IE (1) IE74167B1 (pt)
IL (1) IL92270A (pt)
MX (1) MX18317A (pt)
NZ (1) NZ231369A (pt)
PH (1) PH26103A (pt)
PT (1) PT92270B (pt)
RU (3) RU2002749C1 (pt)
ZA (1) ZA898612B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097943A (en) * 1986-02-05 1992-03-24 Nisshinbo Industries, Inc. Bobbin transfer appartaus in spinning processes
US5074401A (en) * 1988-06-16 1991-12-24 Kabushiki Kaisha Toyoda Jidoshokki Seisakusho Bobbin-carrying apparatus of a combined fine spinning machine and winder
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
CA2034592C (en) * 1990-01-26 2001-06-05 Ralph R. Pfeiffer Crystalline hydrochloride of new beta-lactam antibiotic and process therefor
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
AU1234999A (en) * 1997-11-10 1999-05-31 Gist-Brocades B.V. Crystallization of beta-lactam compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155548C (no) * 1979-02-10 1987-04-15 Kyowa Hakko Kogyo Kk Fremgangsmaate til fremstilling av optisk aktive cefalosporin-analoger.
DD273634A5 (de) * 1987-10-06 1989-11-22 ����@�����@�����@����k�� Verfahren zur herstellung eines kristallinen monohydrats eines 1-carbacephalosporins
ZA89829B (en) * 1988-02-05 1990-10-31 Lilly Co Eli Crystalline b-lactam solvate
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic

Also Published As

Publication number Publication date
JP2842640B2 (ja) 1999-01-06
CA2002597A1 (en) 1990-05-14
ES2085281T3 (es) 1996-06-01
IL92270A0 (en) 1990-07-26
PT92270A (pt) 1990-05-31
DK563689D0 (da) 1989-11-10
RU2028298C1 (ru) 1995-02-09
IE893641L (en) 1990-05-14
KR0145556B1 (ko) 1998-08-17
IE74167B1 (en) 1997-07-02
RU2002749C1 (ru) 1993-11-15
HUT52507A (en) 1990-07-28
IL92270A (en) 1994-10-21
GR3019677T3 (en) 1996-07-31
EP0369687A1 (en) 1990-05-23
ZA898612B (en) 1991-07-31
MX18317A (es) 1993-11-01
CA2002597C (en) 1999-03-23
AU614440B2 (en) 1991-08-29
CN1025333C (zh) 1994-07-06
HU203756B (en) 1991-09-30
JPH02180882A (ja) 1990-07-13
CN1042711A (zh) 1990-06-06
KR900007839A (ko) 1990-06-02
RU1833387C (ru) 1993-08-07
DK563689A (da) 1990-05-15
DE68926148D1 (de) 1996-05-09
PT92270B (pt) 1995-08-09
ATE136306T1 (de) 1996-04-15
NZ231369A (en) 1991-03-26
EP0369687B1 (en) 1996-04-03
DK170701B1 (da) 1995-12-11
DE68926148T2 (de) 1996-09-19
AU4457289A (en) 1990-05-31

Similar Documents

Publication Publication Date Title
US5091525A (en) Monohydrate and DMF solvates of a new carbacephem antibiotic
NL8003003A (nl) Tussenprodukten te gebruiken bij de bereiding van cefalosporine antibiotica.
US4977257A (en) DMF solvates of a β-lactam antibiotic
CA2002597C (en) Solvates of b-lactam antibiotic
CA1140112A (en) Broad spectrum cephalosporin antibiotics
US4148817A (en) Process and intermediates for preparing cephalosporin antibiotics
US5639877A (en) Intermediates in the synthesis of cephalosporins
IE56485B1 (en) Improvements in or relating to novel cephalosporin intermediates
CA1339213C (en) Substantially anhydrous crystalline cefadroxil and method for producing it
AU615026B2 (en) Crystalline beta-lactam solvate
KR100308746B1 (ko) 로라카베프이소프로판올레이트및로라카베프이소프로판올레이트를로라카베프일수화물로전환시키는방법
HU180687B (en) Process for preparing 7-acyl-amido-ceph-3-eme-4-carboxylic acid derivatives
US5578720A (en) Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US4098796A (en) P-trimethylsilyloxyphenyl glycyloxyphthalimide
US4178294A (en) p-Trimethylsilyloxyphenyl glycyloxy succinimide
US4091214A (en) De-esterification process for cephalosporins
US4005074A (en) Process for cleaving an imido side chain from penicillins and cephalosporins
US4223134A (en) Process for preparing cephalosporin antibiotics
GB2193213A (en) 6-trifluoromethyl-1H-benzotriazol-1-yl diphenylphosphate and its use in preparing cephalosporin derivatives
KR830002896B1 (ko) 세팔로스포린 유도체의 제조방법
US20060205938A1 (en) Monohydrate solvates of loracarbef
JPS59144787A (ja) 2−オキソアゼチジン誘導体
JPS62228084A (ja) セフアロスポリン誘導体
JPS60233090A (ja) セフエム誘導体の製造方法